Scholarlink

Context <p>Early identification and treatment of meningitis in early infancy is crucial for improved outcomes. However, the commonly used cerebrospinal fluid (CSF) markers for diagnosing meningitis have poor diagnostic accuracy.</p> Objective <p>To assess the diagnostic utility of CSF procalcitonin for diagnosing meningitis in infants with postnatal age less than 90 days.</p> Evidence Acquisition <p>We searched databases, including MEDLINE, Embase, and Scopus, from inception to 15 March 2025. We included observational studies that used CSF procalcitonin as a marker for diagnosing meningitis in infants with a postnatal age of less than 90 days. The risk of bias was assessed using the QUADAS-2, and the certainty of evidence was ascertained using GRADE approach. The bivariate random effect model and hierarchical summary receiver operating characteristic meta-analysis were used to pool data with multiple thresholds.</p> Results <p>Out of 815 retrieved records, seven studies involving 963 infants were included in the meta-analysis. We obtained diagnostic accuracy measures at commonly used threshold cut-offs of 0.20&#xa0;ng/mL and 0.33&#xa0;ng/mL. At a CSF procalcitonin threshold cut-off of 0.20 ng/mL, the pooled sensitivity (95%CI) was 77.1% (49.2%, 92.1%), and the pooled specificity (95%CI) was 68.9% (49.2%, 83.5%). At a cut-off of 0.33 ng/mL, sensitivity was 75.8% (50.1%, 90.7%) and specificity was 75.1% (58.5%, 86.6%). The certainty of evidence remained very low for both sensitivity and specificity.</p> Conclusion <p>CSF procalcitonin has moderate sensitivity and specificity for diagnosing meningitis in infants with postnatal age &lt; 90&#xa0;days. However, wide confidence intervals and very low certainty of evidence limit the reliability of these findings.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cerebrospinal Procalcitonin for Diagnosing Meningitis in Infants Less Than 90 Days: A Systematic Review and Meta-analysis

  • 期刊论文

  • 发表日期：

    2025年10月8日

查看全文
  • Vijay Kumar Krishnegowda,
  • Prathik Bandiya,
  • Debasish Nanda,
  • Anup Thakur

摘要

Context

Early identification and treatment of meningitis in early infancy is crucial for improved outcomes. However, the commonly used cerebrospinal fluid (CSF) markers for diagnosing meningitis have poor diagnostic accuracy.

Objective

To assess the diagnostic utility of CSF procalcitonin for diagnosing meningitis in infants with postnatal age less than 90 days.

Evidence Acquisition

We searched databases, including MEDLINE, Embase, and Scopus, from inception to 15 March 2025. We included observational studies that used CSF procalcitonin as a marker for diagnosing meningitis in infants with a postnatal age of less than 90 days. The risk of bias was assessed using the QUADAS-2, and the certainty of evidence was ascertained using GRADE approach. The bivariate random effect model and hierarchical summary receiver operating characteristic meta-analysis were used to pool data with multiple thresholds.

Results

Out of 815 retrieved records, seven studies involving 963 infants were included in the meta-analysis. We obtained diagnostic accuracy measures at commonly used threshold cut-offs of 0.20 ng/mL and 0.33 ng/mL. At a CSF procalcitonin threshold cut-off of 0.20 ng/mL, the pooled sensitivity (95%CI) was 77.1% (49.2%, 92.1%), and the pooled specificity (95%CI) was 68.9% (49.2%, 83.5%). At a cut-off of 0.33 ng/mL, sensitivity was 75.8% (50.1%, 90.7%) and specificity was 75.1% (58.5%, 86.6%). The certainty of evidence remained very low for both sensitivity and specificity.

Conclusion

CSF procalcitonin has moderate sensitivity and specificity for diagnosing meningitis in infants with postnatal age < 90 days. However, wide confidence intervals and very low certainty of evidence limit the reliability of these findings.